Heron Therapeutics Inc (HRTX) has fallen Monday morning, with the stock decreasing -4.93% in pre-market trading to 4.44. HRTX's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 118 out of 146 industries, the stock ranks higher than 56% of stocks. Heron Therapeutics Inc has fallen 2.51% over the past month, closing at $4.44 on August 22. During this period of time, the stock fell as low as $3.92 and as high as $5.14. HRTX has an average analyst recommendation of Strong Buy. The company has an average price target of $10.10.
HRTX has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on HRTX!